Timing of hepatitis B vaccination: Its effect on vaccine response in health care workers

Vaccine

Volumn 25, Issue 43, 2007, Pages 7568-7572

  Sabidó, Meritxell ^a   Gavaldà, Laura ^a   Olona, Noemí ^a   Ramon, Josep Maria ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Dose schedule; Hepatitis B vaccine; Immunogenicity

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS B; HUMAN; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VACCINATION;

ADULT; AGE FACTORS; FEMALE; HEALTH PERSONNEL; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TIME FACTORS; VACCINATION;

EID: 34848910171     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.025     Document Type: Article

References (30)

1. Bonanni P., and Bonaccorsi G. Vaccination against hepatitis B in health care workers. Vaccine 19 (2001) 2389-2394
2. Centers for Disease Control. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 2005;54(RR-16):1-39.
3. Coates T., Wilson R., Patrick G., André F., and Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 23 (2001) 392-403
4. Averhoff F., Mahoney F., Coleman P., Schatz G., Hurwithz E., and Margolis H. Immunogenicity of hepatitis B vaccine. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 15 1 (1998) 1-8
5. Alimonos K., Nafziger A.N., Murray J., and Bertino Jr. J.S. Prediction of response to hepatitis B vaccine in health care workers: whose titres of antibody to hepatitis B surface antigen should be determined after at three-dose series, and what are the implications in terms of cost-effectiveness?. Clin Infect Dis 26 (1998) 566-571
6. Wood R.C., MacDonald K.L., White K.E., Hedburg C.W., Hanson M., and Osterholm M.T. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 270 (1993) 2935-2939
7. Wong E.K.L., Bodsworth N.J., Slade M.A., Mulhall B.P., and Donovan B. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS 7 (1996) 490-494
8. Fisman D.N., Agrawal D., and Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 35 (2002) 1368-1375
9. Das K., Gupta R.K., Kumar V., Singh S., and Kar P. Association of HLA phenotype with primary non-response to recombinant hepatitis B vaccine: a study from north India. Trop Gastroenterol 25 3 (2004) 113-115
10. Hadler S.C., de Monzon M.A., Lugo D.R., and Perez M. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 7 (1989) 106-110
11. Halsey N.A., Moulton L.H., O'Donovan J.C., Walcher J.R., Thoms M.L., Margolis H.S., et al. Hepatitis B vaccine administered to children and adolescents at yearly intervals. Pediatrics 103 (1999) 1243-1247
12. Wistrom J., Ahlm C., Lundberg S., Settergren B., and Tarnvik A. Booster vaccination with recombinant hepatitis B vaccine 4 years after priming with one single dose. Vaccine 17 (1999) 2162-2165
13. Bayas J.M., Bruguera M., Martin V., Vidal J., Rodes J., and Salleras L.Y. Hepatitis B vaccination in prisons: the Catalonian experience. Vaccine 11 14 (1993) 1441-1444
14. Hollinger F.B., Adam E., Heidberg D., and Melnick J.L. Response to hepatitis B vaccine in a young adult population. In: Szmuness W., Alter H.J., and Maynard J.E. (Eds). Viral hepatitis: 1981 international symposium (1982), Franklin Institute Press, Philadelphia 421-466
15. Jilg W., Schmidt M., and Deinhardt F. Vaccination against hepatitis B: a comparison of three different vaccination schedules. J Infect Dis 160 (1989) 766-769
16. Treadwell T.L., Keeffe E.B., Lake J., Read A., Friedman L.S., Goldman I.S., et al. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med 95 (1993) 584-588
17. ®) in adults. Vaccine 19 (2001) 4710-4719
18. Gandhoke I., Gupta S., Lal S., and Khare S. Immuneresponse to recombinant hepatitis B vaccination in adults. J Commun Dis 35 4 (2003) 249-255
19. Tolosa Martínez N., Tenías Burillo J.M., Pérez Bermúdez B., and Sanchis Álvarez J.B. Factores associados a una respuesta inadecuada a la vacunación contra la hepatitis B en personal sanitario. Rev Esp Salud Pública 72 (1998) 509-515
20. Bolyard E.A., Tablan O.C., Williams W.W., Pearson M.L., Shapiro C.N., and Deitchmann S.D. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 19 (1998) 407-463
21. Mangione R., Stroffolini T., Totsi M.E., Fragapani D., and Mele A. Delayed third hepatitis B vaccine dose and immune response. Lancet 345 (1995) 1111-1112
22. Hadler S.C., and Margolis H.S. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. In: Remington J.S., and Swartz M.N. (Eds). Current clinical topics in infectious diseases 12 (1992), Blackwell Scientific Publications, Boston 282-308
23. Floreani A., Baldo V., Cristofoletti M., Renzulli G., Valeri A., Zanetti C., et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18-year experience in health care workers. Vaccine 22 (2004) 607-610
24. Bock H.L., Kruppenbacher J., Sanger R., Hobel W., Clemens R., and Jilg W. Immunogenicity of a recombinant hepatitis B vaccine in adults. Arch Intern Med 156 (1996) 2226-2231
25. Jilg W., Schmidt M., and Deinhardt F. Four-year experience with a recombinant vaccine. Infection 17 (1989) 70-76
26. West D.J., and Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14 (1996) 1019-1027
27. Centers for Disease Control and Prevention. Hepatitis Surveillance Report No. 59. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.
28. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-15):1-48.
29. Quinley J.C., and Shih A. Improving physician coverage of pneumococcal vaccine: a randomized trial of a telephone intervention. J Community Health 29 (2004) 103-115
30. Vilella A., Bayas J.M., Diaz M.T., Guinovart C., Diez C., Simo D., et al. The role of mobile phones in improving vaccination rates in travelers. Prev Med 38 (2004) 503-509